A drug approved to treat chest pain is being tested as a potential treatment for ventricular arrhythmias, irregular heart rhythms that are associated with increased hospitalizations and death and for which there are limited treatment options for patients with heart disease.
Media Coverage
|
University of Rochester Medical Center